Cargando…

Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion

In response to cardiac ischemia/reperfusion, proteolysis mediated by extracellular matrix metalloproteinase inducer (EMMPRIN) and its secreted ligand cyclophilin-A (CyPA) significantly contributes to cardiac injury and necrosis. Here, we aimed to investigate if, in addition to the effect on the funn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Ignacio, Tesoro, Laura, Ramirez-Carracedo, Rafael, Diez-Mata, Javier, Sanchez, Sandra, Saura, Marta, Zamorano, Jose Luis, Zaragoza, Carlos, Botana, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001911/
https://www.ncbi.nlm.nih.gov/pubmed/33809359
http://dx.doi.org/10.3390/ijms22062902
_version_ 1783671340402737152
author Hernandez, Ignacio
Tesoro, Laura
Ramirez-Carracedo, Rafael
Diez-Mata, Javier
Sanchez, Sandra
Saura, Marta
Zamorano, Jose Luis
Zaragoza, Carlos
Botana, Laura
author_facet Hernandez, Ignacio
Tesoro, Laura
Ramirez-Carracedo, Rafael
Diez-Mata, Javier
Sanchez, Sandra
Saura, Marta
Zamorano, Jose Luis
Zaragoza, Carlos
Botana, Laura
author_sort Hernandez, Ignacio
collection PubMed
description In response to cardiac ischemia/reperfusion, proteolysis mediated by extracellular matrix metalloproteinase inducer (EMMPRIN) and its secreted ligand cyclophilin-A (CyPA) significantly contributes to cardiac injury and necrosis. Here, we aimed to investigate if, in addition to the effect on the funny current (I(f)), Ivabradine may also play a role against cardiac necrosis by reducing EMMPRIN/CyPA-mediated cardiac inflammation. In a porcine model of cardiac ischemia/reperfusion (IR), we found that administration of 0.3 mg/kg Ivabradine significantly improved cardiac function and reduced cardiac necrosis by day 7 after IR, detecting a significant increase in cardiac CyPA in the necrotic compared to the risk areas, which was inversely correlated with the levels of circulating CyPA detected in plasma samples from the same subjects. In testing whether Ivabradine may regulate the levels of CyPA, no changes in tissue CyPA were found in healthy pigs treated with 0.3 mg/kg Ivabradine, but interestingly, when analyzing the complex EMMPRIN/CyPA, rather high glycosylated EMMPRIN, which is required for EMMPRIN-mediated matrix metalloproteinase (MMP) activation and increased CyPA bonding to low-glycosylated forms of EMMPRIN were detected by day 7 after IR in pigs treated with Ivabradine. To study the mechanism by which Ivabradine may prevent secretion of CyPA, we first found that Ivabradine was time-dependent in inhibiting co-localization of CyPA with the granule exocytosis marker vesicle-associated membrane protein 1 (VAMP1). However, Ivabradine had no effect on mRNA expression nor in the proteasome and lysosome degradation of CyPA. In conclusion, our results point toward CyPA, its ligand EMMPRIN, and the complex CyPA/EMMPRIN as important targets of Ivabradine in cardiac protection against IR.
format Online
Article
Text
id pubmed-8001911
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80019112021-03-28 Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion Hernandez, Ignacio Tesoro, Laura Ramirez-Carracedo, Rafael Diez-Mata, Javier Sanchez, Sandra Saura, Marta Zamorano, Jose Luis Zaragoza, Carlos Botana, Laura Int J Mol Sci Article In response to cardiac ischemia/reperfusion, proteolysis mediated by extracellular matrix metalloproteinase inducer (EMMPRIN) and its secreted ligand cyclophilin-A (CyPA) significantly contributes to cardiac injury and necrosis. Here, we aimed to investigate if, in addition to the effect on the funny current (I(f)), Ivabradine may also play a role against cardiac necrosis by reducing EMMPRIN/CyPA-mediated cardiac inflammation. In a porcine model of cardiac ischemia/reperfusion (IR), we found that administration of 0.3 mg/kg Ivabradine significantly improved cardiac function and reduced cardiac necrosis by day 7 after IR, detecting a significant increase in cardiac CyPA in the necrotic compared to the risk areas, which was inversely correlated with the levels of circulating CyPA detected in plasma samples from the same subjects. In testing whether Ivabradine may regulate the levels of CyPA, no changes in tissue CyPA were found in healthy pigs treated with 0.3 mg/kg Ivabradine, but interestingly, when analyzing the complex EMMPRIN/CyPA, rather high glycosylated EMMPRIN, which is required for EMMPRIN-mediated matrix metalloproteinase (MMP) activation and increased CyPA bonding to low-glycosylated forms of EMMPRIN were detected by day 7 after IR in pigs treated with Ivabradine. To study the mechanism by which Ivabradine may prevent secretion of CyPA, we first found that Ivabradine was time-dependent in inhibiting co-localization of CyPA with the granule exocytosis marker vesicle-associated membrane protein 1 (VAMP1). However, Ivabradine had no effect on mRNA expression nor in the proteasome and lysosome degradation of CyPA. In conclusion, our results point toward CyPA, its ligand EMMPRIN, and the complex CyPA/EMMPRIN as important targets of Ivabradine in cardiac protection against IR. MDPI 2021-03-12 /pmc/articles/PMC8001911/ /pubmed/33809359 http://dx.doi.org/10.3390/ijms22062902 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hernandez, Ignacio
Tesoro, Laura
Ramirez-Carracedo, Rafael
Diez-Mata, Javier
Sanchez, Sandra
Saura, Marta
Zamorano, Jose Luis
Zaragoza, Carlos
Botana, Laura
Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title_full Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title_fullStr Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title_full_unstemmed Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title_short Ivabradine Induces Cardiac Protection against Myocardial Infarction by Preventing Cyclophilin-A Secretion in Pigs under Coronary Ischemia/Reperfusion
title_sort ivabradine induces cardiac protection against myocardial infarction by preventing cyclophilin-a secretion in pigs under coronary ischemia/reperfusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001911/
https://www.ncbi.nlm.nih.gov/pubmed/33809359
http://dx.doi.org/10.3390/ijms22062902
work_keys_str_mv AT hernandezignacio ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT tesorolaura ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT ramirezcarracedorafael ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT diezmatajavier ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT sanchezsandra ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT sauramarta ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT zamoranojoseluis ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT zaragozacarlos ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion
AT botanalaura ivabradineinducescardiacprotectionagainstmyocardialinfarctionbypreventingcyclophilinasecretioninpigsundercoronaryischemiareperfusion